The prognostic value of both PDGFRβ and VEGFR2 was confirmed at the mRNA level by our analysis of three independent publicly available microarray datasets, demonstrating a significant correlation between higher PDGFRβ and VEGFR2 gene expression and reduced overall survival of ovarian cancer patients [19–22]. This evidence concerns the gene KDR and ovarian carcinoma.